HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Neurobiotechnology & Brain Engineering

Neurobiotechnology & Brain Engineering

Exploring the brain’s complexity through technological and molecular innovation, neurobiotechnology & brain engineering focuses on decoding neural function and repairing or enhancing the nervous system. From brain-computer interfaces and optogenetics to neuroprosthetics and neural organoids, this multidisciplinary field merges bioengineering, neuroscience, and biotechnology. Researchers in Neurobiotechnology & Brain Engineering are advancing treatments for neurological disorders such as Parkinson’s, epilepsy, and spinal cord injuries through stem cell therapies, gene editing, and neural regeneration strategies. Additionally, wearable neurodevices and biosensors offer real-time monitoring of brain activity, supporting applications in mental health, cognitive enhancement, and rehabilitation. The field not only deepens our understanding of brain physiology but also introduces cutting-edge tools for neural repair and augmentation.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a